IVL Specifically Designed to Crack Challenging
BTK Calcium and Minimize Vessel Recoil
Shockwave has completed the DISRUPT BTK clinical study, demonstrating the effectiveness and safety of IVL in small diameter, difficult-to-treat BTK arteries - no procedural complications, low residual stenosis and no TLR at 30 days in severely calcified CLI patients.
But, right now we're in the early phases of the R&D program. In the meantime, don't miss the IVL application that heart teams are embracing already — maintaining transfemoral TAVR access through heavily calcified iliacs by using IVL.